Clinical trial
Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study.
NCT02099851 is registered in ClinicalTrials.gov with Noblewell as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study.
- Lead sponsor
- Noblewell
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2014
- Completion date
- Not reported
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.